XML 46 R35.htm IDEA: XBRL DOCUMENT
v3.25.1

EPS Calculation (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Schedule of Reconciliation of the (Loss)/Earnings and Shares used in Calculating Basic and Diluted EPS | The following table presents a reconciliation of the earnings/(loss) and shares used in calculating basic and diluted earnings/(loss) per share for the three months ended March 31, 2025 and 2024:
|  | Three Months Ended March 31, |  |
(In Thousands, Except Per Share Amounts) |  | 2025 |  | 2024 |  |  |  |
Basic Earnings/(Loss) per Share: |  |  |  |  |  |  |  |
Net income/(loss) to common stockholders |  | $ | 41,176 |  |  | $ | 23,213 |  |  |  |  |
Dividends declared on preferred stock |  | (8,219) |  |  | (8,219) |  |  |  |  |
Dividends, dividend equivalents and undistributed earnings allocated to participating securities |  | (206) |  |  | (167) |  |  |  |  |
Net income/(loss) attributable to common stockholders - basic |  | $ | 32,751 |  |  | $ | 14,827 |  |  |  |  |
Basic weighted average common shares outstanding |  | 103,777 |  |  | 103,173 |  |  |  |  |
Basic Earnings/(Loss) per Share |  | $ | 0.32 |  |  | $ | 0.14 |  |  |  |  |
Diluted Earnings/(Loss) per Share: |  |  |  |  |  |  |  |
Net income/(loss) to common stockholders - basic |  | $ | 32,751 |  |  | $ | 14,827 |  |  |  |  |
Dividends, dividend equivalents and undistributed earnings allocated to participating securities |  | — |  |  | — |  |  |  |  |
Interest expense on Convertible Senior Notes |  | — |  |  | — |  |  |  |  |
Net income/(loss) attributable to common stockholders - diluted |  | $ | 32,751 |  |  | $ | 14,827 |  |  |  |  |
Basic weighted average common shares outstanding |  | 103,777 |  |  | 103,173 |  |  |  |  |
Unvested and vested restricted stock units |  | 1,602 |  |  | 2,076 |  |  |  |  |
Effect of assumed conversion of Convertible Senior Notes to common shares |  | — |  |  | — |  |  |  |  |
Diluted weighted average common shares outstanding (1) |  | 105,379 |  |  | 105,249 |  |  |  |  |
Diluted Earnings/(Loss) per Share |  | $ | 0.31 |  |  | $ | 0.14 |  |  |  |  |
(1)At March 31, 2025 and 2024, the Company had approximately 800,000 and 478,000 equity instruments outstanding that were excluded from the calculation of diluted EPS for the three months ended March 31, 2025 and 2024, as they were determined to be anti-dilutive. These equity instruments reflect RSUs (based on current estimate of expected share settlement amount) with a weighted average grant date fair value of $10.37 and $11.25, respectively. These equity instruments may have a dilutive impact on future EPS.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration